July 14, 2014, Monday

The talks follow AbbVie’s revised offer to pay about $51 billion for Shire, which has its headquarters in Ireland and is listed in London. Shire confirmed the talks on Friday but did not provide details of the discussions.

July 9, 2014, Wednesday

The Irish drug maker Shire said that as an independent company it could more than double its revenue in the next seven years, adding that it expected double-digit sales growth each year from its current portfolio of drugs.